The highly-anticipated Bankman Fried AI trial has finally begun this week. After many months of preparation and debate amongst the tech and finance communities, the trial marks a milestone in the advancement and regulation of Artificial Intelligence (AI). OpenAI, the San Francisco-based startup behind various AI research projects, is among the many companies involved in the trial. The company is a notable participant in this trial, as it is currently developing its own AI-based chips. At the heart of the Bankman Fried trial is the important question of whether or not regulatory standards need to be set for the use of AI in the finance industry. The trial was sparked by a legal dispute between Bankman Fried, a financial services company, and OpenAI, as Bankman Fried was accused of using AI in a manner that violated consumer protection regulations. By taking part in the high stakes trial, OpenAI has a vested interest in setting a regulatory framework for the use of AI in the financial industry. Furthermore, the trial also provides an opportunity for OpenAI to gain more insight into what the industry may require of its AI-based chips. The trial is expected to last for several weeks and will have far-reaching implications, as several other players have expressed an interest in the case. Ultimately, the trial will provide both clarity and guidance in a field where it is all too often difficult to find an ethical course, particularly when it comes to the increasingly complex ethical conundrums posed by the heavy reliance on AI technology. The decision of the court could potentially shape the future for AI-driven finance, and for AI-driven applications in all areas of technology, for years to come. For OpenAI and other participants in the trial, the outcome could have a major impact in terms of understanding the industry standards for AI-based chips, as well as potential opportunities for monetization.